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Personalized medicine is rapidly advancing field of
healthcare. Each person is unique by the genetic, geno-
mic, proteomic and metabolomics background, which
are playing important role also in the individual disease
mechanisms and the efficacy of the treatment. Besides
all abovementioned aspects the impact of gender on the
pathogenetic mechanisms of different diseases is not
often considered.
The aim of the study
Immune status of the individual is playing important role
in health and disease. The differences in immune
responses between males and females have been reported.
It has been proposed that sex hormones and their balance
may influence the immune system.
The aim of study was to examine possible gender differ-
ences in one of the malignancies – chronic lymphocytic leu-
kemia (CLL). The status of the immune – hypothalamic-
pituitary-gonadal circuit and immune activity was
investigated.
Material and methods
132 patients with CLL, 76 males and 56 females were stu-
died. 38 healthy age and sex matched subjects served as
controls. Immune status was investigated by mitogen sti-
mulation of peripheral blood lymphocytes. Phytohemagglu-
tinin (PHA), concanavalin A (Con A) dextran sulphate
(DxS) were used as mitogens. An optimized whole blood
method to study the mitogenic lymphocytic proliferation
was used [1]. Proliferation was measured by 3H-thymidine
uptake and assessed autoradiographically. Results were
expressed in mean stimulation index. To study the hormo-
nal balance concentrations of plasma adrenocorticotropic
hormone (AKTH), serum cortisol (C), follicle stimulating
hormones (FSH), luteinizing hormone (LH), testosterone
(T) and 17ß-estradiol were measured.
Results
CLL patients demonstrated significant decrease of
T-lymphocytes function. Remarkable increase of serum
cortisol level was found in CLL patients, whereas no
changes in ACTH concentrations were demonstrated.
We can guess the existence of serious dysregulation of
the hypothalamic-pituitary-adrenal axis. Values of FSH,
LH and E in men with CLL were significantly higher
than in healthy persons. No significant differences were
demonstrated in the levels of abovementioned hormones
in female CLL patients. The dysbalance of sex hormones
can influence the immune functions. Negative correla-
tion has been demonstrated between E/T radio and
T-lymphocyte function in male CLL patients. We can
guess that earlier observed worse survival of male CLL
patients compared to females can be connected with the
impact of sex hormones dysbalance on immune regula-
tion and through that to overall pathogenesis of disease.
Males and females normally have dimorphic immune
response. It is reasonable to suggest that in pathologic
conditions (for example in CLL) immune regulation is
altered in different ways in males and females. Sex hor-
mones dysbalance in CLL can be responsible for that.
Further studies are needed to clarify whether CLL male
and female patients would need different therapy in
connection with diversity of pathogenesis and disease
progression.
In conclusion, there are some arguments presented that
gender-based medicine will become irrelevant if all indivi-
dual factors can be taken into account. However, large
databases reveal that gender remains as an independent
risk factor. It is important to consider and find out the
impact of gender differences in individualised medicine
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